QS Research · Michael Burry's Scion Capital analyst template · 2006
British American Tobacco p.l.c. (BTI)
As of 2026-11-18 · 11/15 boxes filled from SEC filings and market data
Report price $59.16 (close 2026-11-17); latest close $56.84 (2026-11-20), -3.9% since the report; figures re-marked at the latest close
Conclusion: PASS
Conviction low · base case none · downside -20% · upside +11%
At $59.16 the market capitalises BTI at $136.80B, paying 15.8x FY2025 tax-normalized operating earnings and 13.3x FY2025 GAAP net income against guidance for 3-5% constant-FX revenue growth and adjusted EPS growth toward the middle of 5-8%. The reverse DCF requires -4.6% revenue a year for ten years, below the -1.0% delivered in FY2025 and the guided growth, so the market is pricing decay rather than the base business. Even so, the asymmetry is not enough to act: there is no base case, because no comparable peer multiple sets one and a base at today's multiple is today's price by construction. The downside case is $45.26, -23.5%, from a -10.0% earnings case at a compressed P/E of 13.43x (today 15.8x). The upside case is $63.01, +6.5%, from +6.5% earnings at today's P/E of 15.8x. With the call resting on those two cases alone, the reward does not cover the downside, so the call is PASS with low conviction.
Key numbers
- Share price: $56.84
- Market cap: $131.44B
- Latest financial period: FY Dec 2025 to Dec 31, 2025
- Revenue (FY Dec 2025): £25.61B
- P/E (FY Dec 2025): 12.8x
- FCF yield: 5.8%
- Price / book: 2.16x
- P/E, operating (tax-normalized) (FY Dec 2025): 15.2x
- EV / FCF (FY Dec 2025): 22.6x
- Revenue growth (latest fiscal year): -1.0%
- ROIC (FY Dec 2025): 10.1%
- WACC: 5.2%
- Economic profit spread: +4.9 pts
The 15 boxes
- ✓ 1. Long-form business notes
BAT is a £25.6bn-revenue (FY2025) multi-category nicotine group, still overwhelmingly combustible: cigarettes and other combustibles were £20,201m, or 78.9% of FY2025 revenue, against £3,621m (14.1%) from New Categories (Vapour, Heated Products, Modern Oral) and £1,043m (4.1%) Traditional Oral. It sells in over 140 markets for combustibles, run through three regions where the U.S. alone was £11,534m of FY2025 revenue, and manufactures through 36 fully integrated cigarette facilities in 35 markets. Between FY2020 and FY2025 revenue was broadly flat (£25.78B to £25.61B) while FY2025 operating income was £10.00B but operating cash flow fell to £6.34B from £10.12B; the mix is shifting via Modern Oral (+47.4% to £1,165m in FY2025) even as Vapour fell 10.4% to £1,542m. The newest figures here are FY2025 (year ended 31 December 2025, 20-F dated 2026-02-13); FY2026 gross capex guidance is around £750 million.
- ✓ 2. Competitive advantage
British American Tobacco has the accounting signature of a durable franchise rather than a commodity: FY2025 revenue of £25.61B produced £10.00B of operating income (about 39%), revenue has sat inside a narrow £25.61B–£27.66B band in every year FY2020–FY2025, and capex of £460M–£551M a year is dwarfed by operating cash flow of £6.34B–£10.71B. What the sources support is scale plus brand ownership, not a named competitive position — no competitor, market share or volume/price-mix data appears in them. The blemish is reported-earnings volatility: an FY2023 operating loss of £15.75B and FY2024 net income exceeding operating income mean only the normal-run years (FY2020–FY2022, FY2025) can carry margin and return conclusions. US litigation and settlement structures are a standing contingent claim that the Group does not provide for.
- ✓ 3. 10-Q takeaways
Latest interim release (H1 2026, six months to 30 June 2026): revenue £12,235m, +1.4% reported/+2.9% constant; adjusted profit from operations up 2.5% to £5,530m at constant, and as adjusted for Canada up 3.5% to £5,421m with adjusted operating margin 43.7%, +30 bps. Reported operating margin fell to 34.9% on £1,160m of adjusting items. Cash conversion was 79.7%, the £1.3bn 2026 buyback is on track, and FY26 guidance is confirmed with 3-5% revenue growth, mid-teens New Categories growth and adjusted diluted EPS growth toward the middle of 5-8%.
- ✓ 4. Corporate governance
Filled; members read this box.
- ✓ 5. Overview of the prior 3 years of 8-K filings
Filled; members read this box.
- ✓ 6. Other significant filings
Filled; members read this box.
- ✓ 7. Chronology of significant news and events
Filled; members read this box.
- ✓ 8. Comparables valuation interpretation
Filled; members read this box.
- ○ 9. Insider trading interpretation
- ○ 10. Earnings-call notes
- ○ 11. Impression of the shareholder letter
- ○ 12. Scuttlebutt overview
- ✓ 13. Valuation and risk/reward summary
Filled; members read this box.
- ✓ 14. Current price suppression and potential catalysts
Filled; members read this box.
- ✓ 15. Conclusions
The call above.
Sign in with a QuantSignals Premium or Gold plan to read every box: each point linked to the SEC filing it came from, the bull and bear case, and the comparables. QS Research powers the signals behind FST, our autonomous trading agent.